Skip to content
ANAVEX
ANAVEX
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
  • JOIN US
Search
  • HOME
  • ABOUT US
  • NEWS
  • PIPELINE
  • INVESTORS
    • Events
    • Share Data
    • Analyst Coverage
    • Code of Conduct
    • Investor Material
  • JOIN US
View allAlzheimer's DiseaseAnavex2-73EventsNews ReleasesPDDPIPELINEPressRett Syndrome
Apr52019

Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference

April 5, 2019
Mar282019

Anavex Life Sciences Presents Data On ANAVEX®2-73 in Alzheimer’s Disease at the American Society for Experimental Neurotherapeutics – ASENT 2019 Annual Meeting

March 28, 2019
Mar182019

Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndrome in the U.S.

March 18, 2019
Mar132019

Anavex Life Sciences to Present at the 31st Annual ROTH Conference 2019

March 13, 2019
Mar112019

Anavex Life Sciences Reaches 50% Enrollment Threshold in ANAVEX®2-73 Parkinson’s Disease Dementia (PDD) Phase 2 Study Ahead of Schedule

March 11, 2019
Mar62019

Anavex Life Sciences to Present at the Cowen 39th Annual Health Care Conference 2019

March 6, 2019
Mar42019

Anavex Life Sciences Reports Publication of New Data that Show ANAVEX®2-73 Induces Cellular Recycling Process Linked to the Prevention and Treatment of Age-Associated Diseases

March 4, 2019
Feb72019

Anavex Life Sciences Reports Fiscal 2019 First Quarter Financial Results And Provides Clinical Study Updates

February 7, 2019
Feb42019

Anavex Life Sciences to Present at the 2019 BIO CEO & Investor Conference

February 4, 2019
Jan312019

Anavex Life Sciences to Announce Fiscal 2019 First Quarter Financial Results on Thursday, February 7th, 2019

January 31, 2019
Jan22019

Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer

January 2, 2019
Dec122018

Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update

December 12, 2018
1
23
…45678…
9101112131415161718192021222324252627282930313233343536373839404142
43

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved

Go to Top